Marc Siegel

Official Title

Associate Professor, Department of Medicine, School of Medicine and Health Services, The George Washington University

Current HIV/AIDS Research Activities:

 Principal Investigator in several HIV Prevention studies:

• A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men
• A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection among men and transgender persons who have sex with men.
• The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in young MSM of color in Washington, DC
• Weight change associated with switching to integrase inhibitor-based antiretroviral regimens in HIV-infected subjects

Current HIV/AIDS Educational Activities:

• Teaching of fellows, residents and medical students rotating through the Infectious Disease service at GW Hospital and in the outpatient Infectious Disease clinic

Current HIV/AIDS Clinical Activities:

• Taking care of HIV-infected patients in the MFA outpatient clinic as well as in the inpatient setting at George Washington University Hospital